The Board denied an initial evaluation in excess of 10 percent for seborrheic dermatitis of the face and scalp, finding that the condition is appropriately rated at 10 percent.
The deciding factor: The Board found no evidence of constant itching or exudation, which are required for a higher rating under Diagnostic Code 7806. The veteran's skin condition was characterized as productive of only mild scaling and erythema.
- Claimed conditions
- seborrheic dermatitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- July 27, 2000
- Citation
- 0019761
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0019761.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for service connection for alopecia areata or alopecia androgenic, pseudofolliculitis barbae, and seborrheic dermatitis due to a need for additional evidence.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
- Remanded (sent back)
The Board remands the matter for further development to ensure compliance with previous remand instructions, specifically regarding obtaining a medical opinion from an appropriate specialist and notifying the Veteran about the unavailability of his separation examination.
- Partly granted
The Board granted an initial 30 percent rating for migraine headaches prior to December 5, 2016, and a 50 percent rating from May 31, 2024. The claims for increased ratings for Raynaud's syndrome and seborrheic dermatitis were denied.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.